Perspectives: Compliance Advisor

Ultrafine Particles Come Under the Microscope

 

Nanotechnology is an umbrella term for the science and technology of controlling the structure and properties of materials and systems at the scale of 10-9 meters , 1/100,000 the width of a human hair, or less than 0.1 . Growth projections for nanotechnology applications are 33% a year, according to the National Science Foundation, which has estimated that by 2015 such applications may total $1 trillion in the global economy. The federal government's support of nanotechnology is illustrated by Congress's swift enactment of The 21st Century Nanotechnology Research and Development Act on Dec. 3, 2003. This authorizes $3.7 billion over four years in federal support for nanotechnology.

The strong growth prospects of nanotechnology are prompting an increase in government attention to the potential health effects of nano- and other ultrafine particles (UFPs), which can be even smaller: less than 0.01 . So, this column reviews this interest and the nascent stage of research into these health effects.

Are there health risks?

Questions about the health risks posed by nanotechnology have arisen in the last few years. Almost all of the current, modest body of research relates to naturally occurring UFPs rather than particles produced by nanotechnology. UFPs are ubiquitous in urban areas, in the form of combustion soot, diesel exhaust particles, and products of gasoline exhaust and industrial processes.

Research so far on health effects is limited. Some studies link UFPs with respiratory tract toxicity and indicate that UFPs pose a greater risk of producing an inflammatory response in the lungs than larger particles. These studies show the ability of UFPs to cross the blood-brain barrier, which has the potential to adversely affect the central nervous system. Most recently, on June 1, the American Heart Association issued a statement that exposure to airborne particulate matter poses an increased risk of death due to heart disease. According to the statement, several studies link a greater incidence of heart disease with exposure to particulate pollution. Some experts say that such UFPs ultimately may present a far more substantial health threat than particulate byproducts of nanotechnology applications.

Researchers recommend undertaking inhalation studies to try to discover the operative toxicity mechanisms causing these adverse effects. The federal government agrees, and several federal agencies, including the National Institute for Occupational Safety and Health (NIOSH), the National Toxicity Program (NTP), EPA, and the Food and Drug Administration (FDA), are engaged in such research.

Some work will focus specifically on nanomaterials. For instance, NTP intends to evaluate in research animals the toxic and carcinogenic potential of inhalation exposure to quantum dots (tiny devices that contain a droplet of free electrons) and nanotubes. EPA also is slated to initiate $4 million in research beginning in fiscal year 2004 to investigate the toxicology of certain manufactured nanomaterials.

Occupational hazards also are a primary focus of current government concern. NIOSH has staked out nanotechnology as a key research area and is now developing a National Nanotechnology Research Center to coordinate its research initiatives. NIOSH acknowledges that more research is necessary to understand the effects of exposure to nanoparticles.

Another area NIOSH has identified for further study is the potential toxicity of nanoparticles that contact skin. In vitro assays have yielded strong evidence of oxidative stress and the destruction of dermal cell structure. Further research is needed to understand the relationship between nanoparticles and dermal sensitization or irritation.

The research now underway will shed more light on the toxicity of UFPs and nanoparticles. Companies employing or planning to use nanotechnology should monitor these developments to ensure that their practices and hazard communication strategies remain current and fully reflect health effects research in these areas.

By Lynn Bergeson, regulatory editor. She is a founding shareholder of Bergeson & Campbell, P.C., a Washington, D.C.-based law firm concentrating on chemical industry issues. The views expressed herein are solely those of the author.

More from this perspective...

Title

2010 Elections Could Impact EPA Programs

Some new senators may take a hard line against EPA program expansion.

12/28/2010

SCPA Delays Could Impact Industry

Adoption and implementation of potentially "game changing" regulations are now unclear.

01/11/2011

EPA Expands Endocrine Disruptor Testing

Agency mandates screening of more chemicals and issues guidance

02/17/2011

OSHA Updates PPE Standards

Several key changes help clarify the use of personal protective equipment

03/15/2011

EPA Issues Final Rules for Boilers

New subcategories place emission limits on different types of boilers.

04/19/2011

Could TSCA Reform Be Coming Soon?

Proposal introduces significant new requirements and expansions in others

05/09/2011

U.S. Wants More Transparency in Trade

New memorandum focuses on encouraging trade, coordination and public participation.

06/03/2011

U.S. Issues Guidance for Regulating Nanotechnology

Document recommends future regulation and oversight not inhibit trade or innovation.

07/21/2011

EPA Moves Ahead With BPA Action Plan

Agency seeks input on best approach to determine bisphenol A's risk to environment.

08/10/2011

EPA Issues Chemical Data Reporting Rule

Companies must contend with significant changes.

09/08/2011

EPA Issues Final Weight-of-Evidence Guidance

Document addresses analysis for endocrine-disruptor Tier 1 screening assays.

10/12/2011

NTP Proposes to Revise RoC Review Process

Suggested changes aim to address industry concerns.

11/15/2011

EPA Registers Nanosilver As Active Ingredient

Silver-based antimicrobial pesticide is first such product to gain conditional registration.

12/15/2011

EPA Proposes New Use Rules

Proposal could limit the use of 14 nanoscale substances.

01/16/2012

NRDC Sues EPA Over Nanosilver

Lawsuit challenges approval of product before all required data are submitted.

02/15/2012

EPA Fines Dover Chemical $1.4 Million

Expect EPA to be more creative and ambitious in enforcing TSCA violations.

03/14/2012

EPA Targets Five Chemical Groups

Proposed rules would require companies to report all significant new uses.

04/12/2012

White House Eyes Biobased Products

Government emphasizes commitment to biological research

05/15/2012

OSHA Releases Final HCS Rule

Chemical manufacturers and importers have until 2016 to comply.

06/14/2012

EPA Releases EDSP Management Plan

The assessment program significantly affects many chemicals.

07/26/2012